If the oral treatment for syphilis were as efficient or more efficient than the other modes of treatment, it would have many incidental advantages. Stovarsol,1 spirocid or acetarsone—they are the same product—administered by mouth has given such superior results that we decided to test it in our clinic.
Since 1922 in animal experiments and 1924 clinically, the French have used stovarsol. Later it has been used extensively with great favor in Germany, Austria, Hungary, Czecho-Slovakia and Poland. In this country, Cregor and Gastineau2 tried it for the treatment of adults and compared its efficiency with that of neoarsphenamine.
Oral treatment offers special advantages in infants and children. Any one who has had experience in the treatment of syphilitic children knows with what difficulty and sacrifice a social worker, a bread winner, a busy mother or a caretaker brings a child to the clinic weekly over a long period.
ROSENBAUM HA. STOVARSOL IN THE TREATMENT OF SYPHILIS IN INFANTS AND IN CHILDREN. Am J Dis Child. 1932;44(1):25–30. doi:10.1001/archpedi.1932.01950080035004
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: